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ABSTRACT
The cloning and complete sequencing of gene 2 from
four independently isolated temperature-sensitive
mutants in the phage )29 DNA polymerase (ts2
mutants) is reported. The results obtained indicate that,
in vivo, the mutations only affect the initial steps of the
replication process. Interestingly, three of these
mutations consist in the single amino acid change Ala
to Val at position 492 of the protein. The ts2(24) and
ts2(98) mutant 029 DNA polymerases were expressed,
purified and their thermosensitivity was studied at two
different steps of DNA replication: 1) protein-primed
initiation and 2) elongation of the DNA chain. Whereas
the ts2(24) mutation gave rise to a temperature-
sensitive phenotype in both reactions, the ts2(98)
mutant protein was rather insensitive to the
temperature increase. In addition, the ts2(98) mutant
protein showed clear differences in the activation by
divalent cations. The relationship of these results with
structural and functional domains in the 429 DNA
polymerase are discussed.
INTRODUCTION
Temperature-sensitive mutations have long been recognized as
a powerful tool in structural and functional studies (1,2). Thus,
partial purification and characterization of mutationally altered
T4 DNA polymerases (3) was central for demonstrating the
postulated 'editing' function of the resident 3' to 5' exonuclease
activity (4) and for the establishment of structural-functional
relationships (5). In the case of Bacillus subtilis phage 429 DNA
replication the analysis of a collection of temperature-sensitive
mutants (6,7) played a crucial role in demonstrating the proposed
mechanism of protein-primed initiation (8) and in the
identification of the different cistrons involved in viral DNA
synthesis (9,10). In this system, a unique viral-encoded DNA
polymerase, protein p2, catalyzes both the formation of the
initiation complex between the terminal protein, p3, and dAMP,
which is the 5' terminal nucleotide at both DNA ends, and its
further elongation (11,12) to produce unit-length 429 DNA
EMBL accession nos X53370 and X53371
(13).In addition, the 429 DNA polymerase has a putative
proofreading 3' to 5' exonuclease activity (14,15). The 429 DNA
polymerase has been included among the group of et-like DNA
polymerases because of its sensitivity to several drugs and
nucleotide analogs (16,17) and by the presence of amino acid
sequences highly conserved in this group of DNA polymerases
(17). Further structural-functional relationship analysis, using
targeted mutagenesis, has revealed that the 429 DNA polymerase
is structurally similar to the Klenow fragment of E. coli DNA
polymerase I: the 3' to 5' exonuclease activity is located in the
amino-terminal portion whereas the synthetic activities (initiation
and elongation) are associated to the carboxy-terminal part
(18; 19). In this paper we report the analysis, both in vivo and
in vitro, of several independently isolated ts2 mutants of 429.
The results obtained are discussed in terms of structural and
functional implications, correlating the position of each mutation
with both, reported and new conserved regions.
MATERIALS AND METHODS
Nucleotides, reagents, proteins and templates
Unlabelled nucleotides were purchased from Pharmacia P-L
Biochemicals. (cx-32P)dNTPs (410 Ci/mmol), (methyl-3H)
thymidine (48 Ci/mmol), (35S)methionine (1000 Ci/mmol) and
(a-35S)dATP (600 Ci/mmol) were obtained from Amersham
International plc. 429 terminal protein and protein p6 were
purified as described (20,21). Restriction endonucleases, T4 DNA
ligase and Klenow fragment E. coli DNA polymerase I were from
New England Biolabs. Sequenase 2.0 version of T7 DNA
polymerase was from United States Biochemical Corporation.
Rabbit anti-p2 serum was obtianed by using highly purified wild-
type 429 DNA polymerase (p2) as antigen following conventional
methods. The IgG fraction was purified by affinity
chromatography on a protein A-Sepharose column. Fungal
proteinase K, chromatographically purified, was from Merck.
The drug 6(p-hydroxyphenylazo)uracil (HPUra) was a gift from
Imperial Chemical Industries. EcoRI-digested 4)29 DNA was
prepared from proteinase K-treated 4)29 DNA (22).The 429
DNA-protein p3 complex was isolated as described(23).
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Bacteria, plasmids and phages
Bacillus subtilis 1 lONA try - spoA- su - (24) was used as host
bacteria. Wild-type 029 or mutant susl4(1242), which produces
a normal burst and delayed lysis of the infected bacteria under
restrictive conditions (25), were used. Mutants ts2(24), ts2(98),
ts2(99) and ts2(112) were from the collection of Talavera et al.(6).
Double mutants with sus14(1242) were generally used to produce
a delayed lysis of the infected bacteria. The nomenclature used
for the 029 mutants is that described by Mellado et al. (26).
Plasmids pBR322 (27) and pT7-4 (28) were used as cloning
vectors. The E. coli K- 12 strain K514 was used as host for
transformation. The E. coli B lambda lysogens BL2 1 (DE3),
BL21 (DE3)plysS and BL2 1 (DE3)plysE (29) were used for
expression of the mutant proteins.
DNA manipulations
Plasmid and phage DNA preparations, purification of DNA
fragments, ligation, transformation, antibiotic selection of
recombinants and agarose and polyacrylamide gel electrophoresis
were as described (30). Plasmid DNA minipreparations (31) were
direct substrates for sequencing by the dideoxy chain-termination
method (32). A collection of synthetic oligodeoxynucleotides,
complementary to 029 gene 2 sequences, were used as
sequencing primers. The annealing was at 37°C before incubation
with the Klenow fragment ofDNA polymerase I at 50°C or with
the Sequenase 2.0 version of T7 DNA polymerase at 37°C.
Pulse-labelling of bacteria infected with (29 ts mutants: shift-
up experiments
B.subtilis lIONA was grown at 30°C in defined medium (33).
When the cell concentration was 108/ml the bacteria was
concentrated five times in defined medium containing amino acids
(0.5 mM) each, uridine (200,g/ml) and HPUra (100lOg/ml) and
infected with the mutant indicated in each case at a multiplicity
of infection of 20. After 45 min at 30°C, 0.05 ml of the infected
culture was diluted 5-fold into defined medium supplemented with
(methyl-3H)thymidine (200 ItCi/ml) preheated at 45°C. The
mixture was immediately placed at 45°C and, at different times,
samples were withdrawn and trichloroacetic acid (TCA)-insoluble
radioactivity was determined. To chase the DNA labelled after
infection with the different mutants, a 200-fold excess of non-
radioactive thymidine was added after 4 min. At different times
samples were withdrawn for alkaline sucrose gradient
centrifugation and processed essentially as described by Mellado
et al.(34). Proteinase K-treated 029 DNA was used as internal
unit-length marker.
Induction of cell cultures, analysis of cellular protein and
purification of ¢29 DNA polymerase mutants
The E.coli strain BL21(DE3)plysS (29), transformed with the
different 029 gene 2-containing recombinant plasmids pMBw2,
pMB24 and pMB98, corresponding to the wild-type gene 2 or
mutants ts2(24) and ts2(98), respectively, was grown at 30°C
in LB medium, in the presence of ampicillin (100 4g/ml) and
chloramphenicol (34 atg/ml), until an optical density = 0.45 at
600 nm. The cultures, induced by addition of 1 mM IPTG, were
maintained at 30°C for 30 min and then rifampicin (100 Ag/ml)
was added and the incubation was continued for 40 additional
min. When radioactive labelling of induced cultures was carried
out, (35S) methionine (10 MCi;1000 Ci/mmol) was added to
samples (25 ,l) removed at different times from cultures grown
in the same conditions described above but in minimal medium
(35). The induced 029 DNA polymerase mutant polypeptides
were identified by autoradiography and Coomassie-Blue staining
of SDS-polyacrylamidw gel electrophoretic analysis (36). The
overexpressed mutant proteins were purified as described (11)
with slight modifications.The protein concentration was
determined by radioimmunoassay and SDS-polyacrylamide gel
electrophoresis.
Protein p3-dAMP complex formation (initiation assay)
The initiation assay contained, in 25 Al, 50 mM Tris-HCl, pH
7.5, 10 mM MgCl2 or 1 mM MnCl2, 20 mM (NH4)2SO4, 1
mM dithiothreitol, 7% glycerol, 50 mM NaCl, 2.5 mg/ml bovine
serum albumin (BSA), 0.25 ,lM (ca-32P)dATP (2.5 MCi), 0.5 yg
of 029 DNA-protein p3, 20 ng of purified terminal protein, either
wild-type ( = 1 ng), ts2(24) ( = 1 ng) or ts2(98) ( = 0.1-0.2 ng)
DNA polymerase, and, when indicated, 2 yg of protein p6, which
stimulates the initiation of k29 DNA replication (21). After
incubation for 10 min at 30°C the reaction was stopped by adding
1O mM EDTA-0. 1 % SDS, the samples were filtered through
Sephadex G-50 spun colums in the presence of 0.1 % SDS and
the excluded volume was further analyzed by SDS-
polyacrylamide gel electrophoresis as described (36). Quantitation
was done by excising from the dried gel the radioactive band
corresponding to the p3-dAMP complex and counting the
Cerenkov radiation, or by densitometric analysis of the exposed
films.
When the temperature sensitivity of the 029 DNA polymerase
mutants was tested, the corresponding protein fraction was
preincubated in 12.5 yl of a mixture containing 50 mM Tris-
HCR, pH 7.5, 10 mM MgCl2 or 1 mM MnCl2, 20 mM
(NH4)2SO4, 1 mM dithiothreitol, 14% glycerol, 100 mM NaCl
and 5 mg/ml BSA. After incubation for 3 min at the indicated
temperatures, the preincubation mixtures were used for the
initiation assay as described above.
Polymerization assay: filling-in reaction
The incubation mixture was as in the initiation assay except that
0.5 ,^g of EcoRI-digested 029 DNA was used as template and
(NH4)2SO4 was not added. Either wild-type or mutant 029
DNA polymerases in the amounts indicated in the initiation assay,
and 0.1 M (ca-32P)dATP (1 PCi) and 200 ,uM dGTP and dTTP
were added. The molar ratio EcoRI ends: enzyme was 26 for
the wild-type and ts(24) DNA polymerases and 130-260 for the
ts2(98) DNA polymerase. After incubation for 10 min at 30°C,
the reaction was stopped and the samples filtered through
Sephadex G-50 spun colums as described above. The excluded
volume was counted (Cerenkov radiation) and analyzed by
agarose gel electrophoresis and autoradiography. Temperature
sensitivity was assayed as described before.
Comparison of amino acid sequences of DNA polymerases
The DNA polymerase sequences compared were the following:
phage T4 (37), phage ¢29 (38), phage M2 (39), phage PRD1
(40), S 1-mitochondrial DNA (41), plasmid pGKL1 (42), plasmid
pGKL2 (43),plasmid pClK1 (44), plasmid pAI2 (45), adenovirus
type 2 (46), vaccinia virus (47), fowl-poxvirus (48), varicella
zoster virus (VZV) (49), herpes simplex virus (HSV-1) (50),
Epstein-Barr virus (EBV) (51), human cytomegalovirus (HCMV)
(52), baculovirus (AcMNPV) (53), REV-3 from yeast (54),
CDC2 from yeast (55), Pol I from yeast (56) and ce from human
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(57). Multiple alignments were obtained by series of binary
(pairwise) alignments followed by shifting by eye to achieve
maximal homology. The following conservative amino acids were
considered: Y,W,F,I,L and V; D,N,Q and E; K and R; S and
T; G and A. Binary alignments were carried out by computer
analysis using the programs BESTFIT, PRETTY and GAP from
the UWGCG (University of Wisconsin Genetics Computer
Group) (58).
RESULTS
DNA synthesis in bacteria infected with 429 ts2 mutants.
Shift-up experiments
Four 029 ts2 mutants (6,7) were used in shift-up experiments
to determine the specific step(s) in DNA synthesis sensitive to
temperature. Figure IA shows that the incorporation of
(methyl-3H) thymidine in cells infected with the delayed lysis
mutant susl4(1242) continued after the shift to 45°C whereas
after infection with the different ts2-susl4(1242) mutants, DNA
synthesis stopped slowly after the shift-up, indicating a
thermosensitive DNA synthesis. Pulse-chase experiments showed
that both in cells infected with the susl4(1242) mutant or with
the different ts2-susl4(1242)mutants the pulse-labelled DNA
shorter than unit-length (not shown) was chased into mature DNA
in 10 minutes after the chase (Fig 1B-D, and not shown). Similar
results had been previously obtained with the ts2(98) mutant (34).
These results strongly suggest that all the mutants are affected
in the initial steps of DNA replication. Therefore, the location
of the mutations could be of special interest for defining critical
amino acid positions for the protein-priming activity of the (29
DNA polymerase. The above experiments do not rule out the
possiblity that the elongation activity could be protected from
thermal inactivation when the DNA polymerase forms part of
the replicative complex.
Cloning, sequencing and expression of gene 2 from the ts2
mutant genes
To increase the amount of the ts2-mutant proteins for purification,
cloning of the corresponding genes in E. coli expression vectors
was undertaken. The c29 DNA HindH B fragment, containing
the whole gene 2 and several other small ORFs (38), was cut
with BclI and cloned in pBR322, obtaining the derivative plasmids
pBts2 (see Fig.2). The latter were used both for sequencing and
subcloning in different expression systems.
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Figure 1. Analysis of the DNA synthesized in bacteria infected with ts2 mutants.
A. Incorporation of (3H)thymidine into B.subtilis 1 lONA infected with the 429
mutants susl4(1242) (closed circles), ts2(98)susI4(1242) (open squares),
ts2(99)sus14(1242) (closed squares), ts2(1 12)susl4(1242) (semi-filled circles) and
ts2(24)sus14 (1242) (open circles). B. subtilis lIONA was grown and infected
at 30°C as indicated in Materials and Methods. After the shift to 450C and
simultaneous addition of (3H)-thymidine, samples of 5 IL were removed at the
indicated times to determine TCA-insoluble radioactivity. B-D. ALkaline sucrose
gradient of extracts of infected bacteria, pulse-labelled and chased. B.subtilis
1 lONA was grown and infected with the indicated 4)29 mutants as described in
Materials and Methods, and 10 minutes after the chase (14 minutes after the shift
to 45°C and addition of (3H)-thymidine), samples of 0.2 ml were removed,
lysed, treated with proteinase K and centrifuged in alkaline sucrose gradients,
as described in Materials and Methods, in the presence of 10 jig of 429 DNA
as unit-length marker. The TCA-insoluble radioactivity (closed circles), and the
absorbancy at 260nm (open circles) were determined in the different fractions.
Sedimentaton was from right to left.
EcoR I
Figure 2. Construction of recombinant plasmids containing gene 2 from 029 ts
mutants. The recombinant plasmids were constructed as described in Results,
2. ApR, ampicillin resistance; TetR, tetracicline resistance; 410,410 promoter
of bacteriophage T7. The top of the figure shows the genetic map and the HindEll
restriction map of bacteriophage 4)29 DNA. Gene 2 is represented by black boxes.
The E.coli strains used for selection and for expression are shown in boxes.
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Sequencing of the ts2 mutant genes was carried out as described
in Materials and Methods. It was found that the ts2(24) phenotype
results from a single change (C to T) at nucleotide 1809 from
the left029 DNA end. This transition generates an amino acid
change from alanine to valine at position 355 of the o29 DNA
polymerase. It was found that mutants ts2(98),ts2(99) and ts2(112)
contain the same change (C to T) at position 1398, changing
alanine 492 to valine. This is specially remarkable taking into
account that these three ts2 mutants were independently isolated;
therefore, this result could be related to a high sensitivity of this
position to the mutagenic agent used (6) or to a critical role of
this position for the structural equilibrium. To rule out possible
cloning artifacts, sequencing on the original viral DNA was
carried out, confirming the above results. From the whole
sequencing of the different gene 2 mutants available (18; this
paper), it was found that all of them contained two additional
changes. One of these, a T to C transition in position 2093 from
the left 429 DNA end, results in a silent mutation (AGT to AGC)
in codon 260 of the 429 DNA polymerase, whereas the second,
a GC to CG transversion at positions 2346 to 2347, changes
codon 176 from alanine to lysine. We found that these changes
were also present in our wild-type gene 2, therefore differing
from the published sequence (38).
To express in E. coli the ts2(24) and ts2(98) 429 DNA
polymerase mutants different strategies and expression systems
were tested, including the one used for the expression of the wild-
type protein (30), based in the PL promoter of phage lambda.
Neither heat nor chemical induction (59) with this system nor
other systems based in the Ptac or Plac promoters were
successful. The low number of clones obtained were able to
express the products encoded in the small ORFs contained in the
cloned fragment, but no 429 DNA polymerase was expressed.
Since all these problems could be related with a high toxicity
level of the mutant proteins we used one of the most regulated
E. coli expression systems, based on the high specificity of the
T7 RNA polymerase for its own promoters (28,29). Figure 2
shows the successful subcloning scheme in which the HindJH/ScaI
fragment from plasmids pBts2 was put under the control of the
110 promoter of bacteriophage T7, contained in the plasmid
pT7 -4 (28).The selection for the ampicillin resistant recombinant
plasmids pMBts2 was carried out in the E. coli strain K514, which
cannot express T7 RNA polymerase. The recombinant plasmids
were used to transform the expression strain BL21 (DE3) and its
derivatives BL21 (DE3)plysS and BL21 (DE3)plysE, which can
express the cloned genes after induction by IPTG (29) as indicated
in Materials and Methods. No expression of the ts DNA
polymerase mutants was obtained when BL21(DE3) was used.
However, using the derivative strains that allow a lower basal
expression in the absence of induction, clones expressing in a
regulated fashion the ts2(24) and ts2(98) mutant proteins were
obtained. The overexpressed mutant proteins were purified as
described in Materials and Methods to assay the thermosensitivity
of the different activities.
Location of the 429 DNA polymerase ts mutations relative
to highly conserved regions in DNA polymerases from
terminal protein-containing genomes
The )29 DNA polymerase seems to be structured in a similar
way to the Klenow fragment of E. coli DNA polymerase I (18).
The amino-terminal third of the molecule contains the 3'to
5'exonuclease activity whereas the protein-priming and DNA
polymerase activities are located in the carboxy-terminal domain
(18; 19).Figure 3 shows the location of the ts2 mutations with
respect to the three highly conserved carboxy-terminal domains
previously described (17). Both mutations map in the DNA
polymerase portion involved in the synthetic activities.The ts2(24)
mutation is located between the two motifs DVNSLYP and
NSLYG (Fig. 3, regions 1 and 2), in a conserved region present
only in protein-primed DNA polymerases. The ts2(98) mutation
maps near the YCDTDS motif (Fig. 3, region 3), towards the
carboxy terminus, in a relatively conserved region (Fig. 3, region
4), present in other subfamilies of DNA polymerases including
the Klenow fragment of E. coli DNA polymerase I (to be
published elsewhere). According with the alignment shown in
Figure 3, the T4 DNA polymerase mutant tsL88, with a low
mutator phenotype (5), maps at position 694 (60), very close to
the equivalent position of the ts2(98) mutation. This relationship
and the fact that three independent isolates of 429 map in this
region strengthens its functional or structural importance.
Synthetic activities of the ts2 )29 DNA polymerase mutants.
Temperature-sensitivity analysis
The o29 DNA polymerase mutants, overproduced and purified
as described before, were used to test the temperature-sensitivity
of the synthetic activities i.e., initiation and elongation. Figure
4A shows the results obtained when the different mutants were
assayed in the initiation reaction after preincubation at the
different temperatures as indicated in Materials and Methods.
The ts2(24) DNA polymerase was clearly thermosensitive, being
its initiation activity after preincubation at 42°C about 4% with
respect to that at 30°C. However, the initiation activity of the
ts2(98) DNA polymerase was not temperature-sensitive as was
the case with the wild-type 4)29 DNA polymerase. The
differences in the absolute values at 30°C between the different
DNA polymerases are probably due to the amount of protein
available for the assay. The initiation activity of the ts2(24) DNA
polymerase was not protected from temperature inactivation by
preincubation in the presence of the terminal protein (Fig. 5),
with which it forms a tight complex in the presence of NH4+
ions (61). The effect of the temperature on the initiation activity
of the ts2(24) DNA polymerase seems not only due to a decrease
in affinity for the terminal protein because similar inactivation
by temperature was observed when higher amounts of protein
p3 were added to the preincubated mutant DNA polymerase (not
shown). On the other hand, the polymerization activity of the
ts2(24) DNA polymerase was clearly thermosensitive, being its
activity at 42°C about 6% with respect to that at 30°C (Fig. 4B).
The ts2(98) DNA polymerase showed a slight temperature-
sensitivity, being its activity after preincubation at 42°C about
35 % of that at 300C. The purification level of these proteins did
not allow us to study whether the ts mutations, located in regions
involved in synthetic activities, affect the 3' to 5' exonuclease
activity, situated in the amino-terminal region (18). This is
probably not the case because we have shown that synthetic and
3' to 5' exonuclease activities seem to be located in independent
structural domains (18; 19;unpublished results).
Requirement of activating metal ion for the ts DNA
polymerase mutants
All known DNA polymerases have as a strict requirement for
activity the presence of divalent activating metal ions (Me2+).
In the case of the E.coli DNA polymerase I,X-ray
crystallographic and targeted mutagenesis studies, have involved
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Figure 3. Location of the 029 DNA polymerase ts mutations relative to highly conserved regions in a-like DNA polymerases. The 029 DNA polymerase, showing
the main motifs involved in the catalytic activities is represented; I,JI and Ill indicate the three conserved domains shown to be involved in the 3'-5' exonuclease
activity (18); 1, 2, 3 and 4 indicate regions involved in protein-primed initiation and polymerization activities. B. Multiple alignment of the amino acid sequences
spanning between regions 1 and 2 corresponding to protein-primed DNA polymerases. C. Multiple alignment of regions 3 and 4 corresponding to protein-primed
DNA polymerases and eukaryotic (viral and cellular) a-like DNA polymerases. Numbers in brackets indicate the first residue in each sequence, relative to the N-
terminal end of each polypeptide. Residues conserved in most of the sequences compared and 029 amino acid residues corresponding to ts mutations are indicated
in white letters. Other relevant homology is boxed in grey.
divalent metal ions in both exonuclease (62) and DNA polymerase
activities (L.Beese, J.Friedman and T.A.Steitz, personal
communication). In general, the divalent activator metal ion used
has been Mg2+ The effects observed with other divalent metal
ions have been related to a reduction in the replication fidelity
(63). The 429 DNA polymerase can use either Mg2+ or Mn2+
for initiation and polymerization (Esteban et al., in preparation).
Using 1 mM MnCl2 versus 10 mM MgCl2 the Mn2+/Mg2+
activity ratio for the wild-type 429 DNA polymerase was 3.5
for initiation (Fig. 6A) and 0.2 for polymerization (Fig. 6B).
When the effect of Mn2+ and Mg2+ ions on the activities of the
ts DNA polymerase mutants were compared at 30°C, similar
ratios as with the wild-type DNA polymerase were obtained with
the ts2(24) mutant (Fig.6). However, with the ts2(98)mutant the
ratios were greatly increased, 30 for initiation and 9 for
polymerization (Fig. 6), being this effect not related with
variations in the optimal concentration for each metal. This
behaviour could be related with the proximity of the ts2(98)
mutation to a region proposed to be involved in Me2+ binding,
at the polymerization and initiation active site, mainly represented
by the central motif YCDTDS (19).
DISCUSSION
The analysis of B.subtilis infected with the 429 ts2(24) and the
ts2(98)-group mutants clearly demonstrated that the viral DNA
synthesis was temperature-sentitive, being the initial step(s) of
replication the one(s) affected by the shift to the non-permissive
temperature. These results could be explained if different active
sites in the 429 DNA polymerase (p2) are involved in the
initiation and elongation reactions. Then, all the isolated ts2
mutants would be exclusively affected in the initiation domain.
Recently, targeted mutagenesis studies have demonstrated that
both activities, initiation and elongation, share discrete domains
in the enzyme (19; unpublished results) indicating that there is
not a physical separation of the two activities. The fact that both
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Figure 4. Temperature-sensitivity analysis of the initiation and polymerization activities of the ¢O9 DNA polymerase ts mutants. A. The initiation assay was carried
out as described in Materials and Methods, using 2 Ag of protein p6. After preincubation at the indicated temperatures, the protein fractions were assayed in the
initiation reaction at 30'C, and the p3-dAMP initiation complex formed was analyzed by SDS-polyacrylamide gel electrophopresis. The figure shows the p3-dAMP
band and the numbers in the black columns indicate the relative initiation activity of each DNA polymerase, obtained after preincubation at 370 and 42°C, with
respect to the activity obtained after preincubation at 30'C. B. The polymerization assay (filling-in reaction) was as described in Materials and Methods using EcoRI-
digested 029 DNA as template. (ca-32P)dAMP incorporation was quantitated and analyzed by agarose gel electrophoresis. as described in Materials and Methods.
The positions of the different EcoRI 429 DNA fragments are indicated in the left side. Numbers at the bottom indicate the relative DNA polymerase activity, obtained
after preincubation at 370 and 42°C, respect to the activity obtained after preincubation at 30°C.
mutations, ts2(24) and ts2(98), map 138 amino acids apart and
the structural organization model proposed for the 029 DNA
polymerase (18), do not support the existence of two different
active sites, for initiation and polymerization. Other possiblity
is that the 029 DNA polymerase, when forms part of the
elongation complex, is less sensitive to a temperature shift than
when it is initiating replication. This explanation could be also
related with the behaviour of another 029 mutant, ts2(35)(64).
In this case, parental phage DNA in infected bacteria rapidly
dissociates from the cell membrane after the shift to 45°C,
whereas DNA synthesis does not stop immediately. Both
experimental results could be reconciled assuming that a
temperature-mediated conformational change still allows
elongation to occur but avoids interaction with the cell membrane
and subsequent reinitiation.
The in vitro temperature-sensitivity of the ts2(24) DNA
polymerase, both in the initiation and elongation reactions,
suggests that the in vivo resistance of elongation to a temperature
shift must be due to protection by formation of a replicative
complex. On the other hand, the slight temperature-sensitivity
in elongation and the resistance in initiation activity of the ts2(98)
DNA polymerase cannot account for the in vivo ts phenotype.
This is not the first example reported with a similar behaviour;
in the case of the T4 DNA polymerase mutants tsLl41 and tsS9,
the polymerase activity in vitro was similar at 37°C and at 25°C
(65). TsS9 mutation maps at position 671 in the T4 DNA
polymerase and its phenotype is the consequence of a change
of methionine to isoleucine. Protein tsLl41 also has a single
amino acid change, alanine to valine, at position 737 (60), and
it is considered the archetype of the antimutator mutant (5).
Taking into account the alignment presented in Figure 3, it can
be concluded that both T4 DNA polymerase mutations map near
the related region of 029 DNA polymerase where the ts2(98)
mutation is located. This apparent relationship between the
functional phenotype of different ts DNA polymerases and the
physical mapping supports the possible functional relevance of
this new homologous region (Fig. 3, region 4). The homology
detected with the E. coli DNA polymerase I-like enzymes (Blanco
et al., in preparation) indicates that segment 4 in Figure 3 could
be the homologous one to the segment identified in the E. coli
enzyme as directly involved in dNTP binding by labelling with
pyridoxal 5'-phosphate (66) or azido-dATP (67). The presence
in this region of antagonist phenotypes in T4 DNA polymerase
mutants (tsL88 is a weak mutator and tsLI41, which has the
alaline to valine change, is the strongest antimutator described),
probably indicates that this region could play a crucial role for
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Figure 5. Ineffectiveness of 029 terminal protein to protect ts2(24) DNA polymerase from temperature inactivation. The inhibition assay was carried out as described
in Materials and Methods, after preincubation at 30°C or 42°C, in the absence or presence of 029 terminal protein (60 ng). The p3-dAMP initiation complex formed
was analyzed by SDS-polyacrylamide gel electrophoresis, autoradiography and densitometry of the exposed film.
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Figure 6. Effect of Mn2+ ions on the protein-primed initiation and polymerization activities of the 429 DNA polymerase ts mutants. A.The initiation assay was
carried out as described in Materials and Methods, using either 10 mM MgCl2 or 1 mM MnCl2. After incubation at 30°C, the p3-dAMP initiation complex formed
was analyzed as described in the legend to Fig. 5. B.The DNA polymerase assay (filling-in reaction) was as described in Materials and Methods. After incubation
for 10 min at 30°C using as divalent activating metal ion either 10 mM MgC12 or 1 mM MnCl2 the [ax-32P]dAMP incorporation was quantitated and analyzed by
agarose gel electrophoresis as described in Fig.5. Numbers in black indicate the relative initiation and DNA polymerase activities, when Mn2+ ions were used instead
of Mg2 + ions.
insertion fidelity. Another interesting point, relevant for the
possible analogy between the X29 ts2(98) and the T4 tsLl41 DNA
polymerase mutants is the fact that the latter is other example
in which five independent isolates have the same amino acid
change in the same position (60). This remarkable clustering of
ts mutations in few 'hot spots' has been also detected in other
systems, such as the SV40 large antigen (68) and bacteriophage
T4 lysozyme (2), suggesting that these amino acids could play
crucial roles in organizing the structure of one or more functional
domains. Another feature inferred from these and other studies
(2,65) is that, among the possible changes in alanine, only the
ones to valine or threonine were found to produce the ts
phenotype, independently of the mutagen used for their
generation. Studies on the EcoRI endonuclease (69) have also
rendered similar results, the changes of alanine to valine or
threonine are the ones destroying the endonuclease activity.
Another example of the structural importance of the alanine to
valine change is the fact that the point mutation of Ala 31 to Val
prohibits the folding of reduced chicken lysozyme (67).
The high activity of the ts2(98) DNA polymerase in the
presence of Mn2+ (see Fig.6) is particularly interesting. As far
as we know this is the first example described for a mutant DNA
polymerase that presents alterations in the use of divalent
activating ions. This phenotype could be related with the location
of the ts2(98) mutation in a region proposed to be involved in
dNTP binding (Blanco et al., in preparation) and close to the
proposed Me2+ binding site, mainly represented by the
YCDTDS motif (19).
ACKNOWLEDGEMENTS
We are greatful to Dr. W.F.Studier for the E.coli expression
strains, to Drs.S.Tabor and C.C.Richardson for plasmid pT7-4,
to L.Villar for excellent technical assistance and to J.M.ULzaro
-_- p3-dAMP
B
A--_
B-- _0
C--
4770 Nucleic Acids Research, Vol. 18, No. 16
for his involvement in the initial phase of this work. This
investigation has been aided by research grant 5R01 GM27242-10
from the National Institutes of Health, by grant number PB87
0323 from Direccion General de Investigacion Cientifica y
Tecnica and by an institutional grant from Fundacion Ramon
Areces. M.A.B. was a predoctoral Fellow from Direccion
General de Investigacion Cientifica y Tecnica and A.B.was a
postdoctoral Fellow from Consejo Superior de Investigaciones
Cientificas.
REFERENCES
1. Grutter,M.G., Gray, T.M., Weaver,L.H.,Albert,T. and Matthews, B. W.
(1987). J.Mol.Biol.197,315-329.
2. Albert,T., Dao-pin,S., Nye,J.A., Muchmore,D.C. and Matthews, B.W.
(1987).Biochemistry 26,3754-3758.
3. Muzyczka,N., Poland,R. and Bessman,M.J.(1972). J.Mol.Biol.
247,7116-7122.
4. Brutlag,D.and Kornberg,A.(1972). J.Biol.Chem.247,241 -248.
5. Reha-Krantz,L.J.(1988). J.Mol.Biol.202,711-724.
6. Talavera,A., Jimenez,F., Salas,M. and Viiiuela, E.(1971). Virology 46,
586-595.
7. Talavera,A., Jimenez,F., Salas,M. and Viniuela,E.(1972). Mol. Gen.
Genet. 115,31-35.
8. Salas, M. (1988). Current Topics Microbiol. Inmunol. 136, 72-88.
9. Talavera,A., Salas,M. and Vifiuela,E.(1972). Eur. J.Biochem.31,
367-371.
10. Carrascosa,J.L., Camacho,A., Moreno,F., Jimenez,F., Mellado, R.P.,
Viiiuela,E. and Salas,M.(1976). Eur.J.Biochem.66,229-241.
11. Blanco, L. and Salas, M. (1984). Proc. Nati. Acad. Sci.USA 81, 5325-5329.
12. Watabe, K., Leusch, M. and Ito, J. (1984). Proc. Natl. Acad. Sci. USA
81, 5374-5378.
13. Blanco,L. and Salas,M.(1985). Proc.Natl.Acad.Sci.USA 82,6404-6408.
14. Watabe, K., Leusch, M. and Ito, J. (1984). Biochem. Biophys. Res. Commun.
123, 1019-1026.
15. Blanco,L. and Salas,M.(1985). Nucl.Acids Res. 13,1239-1249.
16. Blanco,L. and Salas,M.(1986). Virology 153,179- 187.
17. Bernad,A., Zaballos,A., Salas,M. and Blanco,L. (1987). The EMBO J.6,
4219-4225.
18. Bernad,A., Blanco,L., Lazaro,J.M., Martin,G.and Salas,M. (1989). Cell
59,219-228.
19. Bernad, A., Lazaro, J.M., Salas, M. and Blanco, L. (1990). Proc. Natl.
Acad. Sci. USA 87, 4610-4614.
20. Zaballos, A. Lzaro, J.M., Mendez, E., Mellado, R.P. and Salas, M. (1989).
Gene 83, 187-195.
21. Pastrana,R., Lazaro,J.M., Blanco,L., Garcfa,J.A., Mendez,E. and
Salas,M.(1985). Nucl.Acids Res.13,3083 -3100.
22. Inciarte,M.R., Vifiuela,E. and Salas,M.(1976). Eur. J. Biochem. 71,
77-83.
23. Pefialva,M.A. and Salas,M.(1982). Proc.Natl.Acad.Sci.USA 79, 5522-
5526.
24. Moreno,F., Camacho,A., Vifiuela,E., and Salas, M. (1974). Virology 62,
1-16.
25. Jim6nez, F., Camacho, A., de la Torre, J., Viiiuela, E. and Salas, M.
(1977). Eur. J. Biochem. 73, 57-72.
26. Mellado,R.P., Moreno,F., Vifiuela,E., Salas,M., Reilly, B.E. and
Anderson,D.L.(1976). J.Virol.19,495-500.
27. Bolfvar,F., Rodriguez,R.L., Greene,P.J., Betlach,M.C., Heyneker, H.L.,
Boyer,H.W., Crosa,J.H. and Falkow, S. (1977). Gene 2,95-113.
28. Tabor,S. and Richardson,C.C. (1985). Proc. Natl. Acad. Sci. USA 82,
1074-1078.
29. Studier,F.W., and Moffatt,B.A. (1986). J. Mol. Biol. 189, 113-130.
30. Blanco, L., Garcia, J.A. and Salas, M. (1984). Gene 29, 33-40.
31. Birnboim,H.C. and Doly,J. (1979). Nucl. Acids Res. 7, 1513-1523.
32. Sanger,F., Nicklen,S. and Coulson,A.R. (1977). Proc. Natl. Acad. Sci. USA
74,5463-5467.
33. Carrascosa,J.L., Vifiuela,E.,and Salas,M.(1973). Virology 56, 291-299.
34. Mellado,R.P., Pefialva,M.A., Inciarte,M. and Salas, M.(1980). Virology
104,84-96.
35. Zaballos,A.,Mellado,R.P. and Salas,M. (1988). Gene 63, 113-121.
36. Laemmli,U.K. (1970). Nature 227,680-685.
37. Spicer,E.K., Rush,J., Fung,C., Reha-Krantz,L.J., Karam, J.D. and
Konigsberg, W.H. (1988). J.Biol.Chem.263,7478-7485.
38. Yoshikawa,H. and Ito,J.(1982).Gene 17,323 -335.
39. Matsumoto,K., Takano,H., Kim,C.I. and Hirokawa, H.(1989). Gene 84,
247 -255.
40. Savilahti,H. and Bamford,D.H.(1987).Gene 57,121-130.
41. Paillard,M., Sederoff,R.R. and Levings,C.S.III (1985). The EMBO J.4,
1125-1128.
42. Stark,M.J.R., Mileham,A.J., Romanos,M.A. and Boyd,A. (1984). Nucl.
Acids Res. 12,6011 -6030.
43. Tommasino, M., Ricci, s. and Galeotti, C.L. (1988). Nucl. Acids Res. 16,
5863 -5878.
44. Oeser, B. and Tudzynski, P. (1989). Mol. Gen. Genet. 217, 132-140.
45. Kempken, F., Meinhardt, F. and Esser, K.(1989). Mol. Gen. Genet. 218,
523 -530.
46. Alestrom,P., Akusjarvi,G., Petterson,M. and Petterson,U. (1982). J.Biol.
Chem.257,13492 - 13498.
47. Earl, P.L., Jones, E.V. and Moss, B. (1986). Proc. Natl. Acad. Sci. USA
83, 3659-3663.
48. Binns, M.M., Stenzler, L., Tomley, F.M., Campbell, J. and Boursnell,
M.E.G. (1987). Nucl. Acids Res. 15, 6563-6573.
49. Davison, A.J. and Scott, J.E. (1986). J. Gen. Virol. 67, 1759-1816.
50. Gibbs, J.S., Chiou, H.C., Hall, J.D., Mount, D.W., Retondo, M.J., Weller,
S.K. and Coen, D.M. (1985). Proc. Natl. Acad. Sci. USA 82, 7969-7973.
51. Baer, R., Bankier, A.T., Biggin, M.D., Deininger, P.L., Farrell, P.J.,
Gibson, T.J., Hatfull, G., Hudson, G.S., Satchwell, S.C., Seguin, C.,
Tuffnell, P.S. and Barrell, B.G. (1989). Nature 310, 207-211.
52. Kourazides, T., Bankier, A.T., Satchwell, S.C., Wiston, K., Tomlinson,
P. and Barrell, B. (1987). J. Virol. 61, 125-133.
53. Tomalski, M.D., Wu, J. and Miller, L.K. (1988). Virology 167, 591 -600.
54. Morrison, A., Christensen, R.B., Alley, J., Beck, A.K., Bemstine, E.G.,
Lemontt, J.F. and Lawrence, C.W. (1989). J. Bacteriol. 171, 5659-5667.
55. Boulet, A., Simon, M., Faye, G., Bauer, G.A. and Burgers, M.J. (1989).
The EMBO J. 8, 1849-1854.
56. Pizzagalli, A., Valsasnini, P., Plevani, P. and Lucchini, G. (1988). Proc.
Natl. Acad. Sci. USA 85, 3772-3776.
57. Wong, S.W., Wahl, A.F., Yuan, P.M., Arai, N., Pearson, B.E., Arai, K.,
Kom, D., Hunkapiller, N.W. and Wang, T.S.F. (1988). The EMBO J. 7,
37-47.
58. Devereux,J., Maeberli,P. and Smithies, 0. (1984). Nucl. Acids Res. 12,
387 -395.
59. Mott,J.E., Grant,R.A., Ho,Y.-S. and Platt,T.(1985). Proc. Natl.
Acad.Sci.USA 82,88-92.
60. Reha-Krantz, L.J. (1989). J. Virol. 63, 4762-4766.
61. Blanco,L., Prieto,I., Gutierrez,J., Bernad,A., Lazaro, J.M., Hermoso,J.M.
and Salas,M.(1987). J.Virol.61,3983-3991.
62. Derbyshire,V., Freemont,P.S., Sanderson, M.R.,Beese,L., Fiedman, J.M.,
Joyce,C.M. and Steitz,T.A.(1988).Science 240, 199-201.
63. Loeb,A.L., Dube,D.K., Beckman,R.A., Koplitz,M. and Gopinathan,K.P.
(1981), J.Biol.Chem.256,3978-3987.
64. McGuire J.C., Gilpatrick,M.W. and Pene, J.J. (1977). Virology 78,234-240.
65. Waard,A., Paul,A.V. and Lehman,I.R.(1965).Biochemistry 54, 1241-1247.
66. Pandey,V.N., Stone,K.L., Williams,K.R.and Modak, M.J. (1987)
Biochemistry 26,7744-7748.
67. Rush, J. and Konigsberg, W.H. (1990). J. Biol. Chem. 265, 4821-4827.
68. Loeber,G., Tevethia,M.J., Schwedes,J.F. and Tegtmeyer, P. (1989).
J.Virol.63, 4426-4430.
69. Yanofsky,S.D., Love,R., McClarin, Rosenberg,J.M., Boyer, H.W. and
Greene,P.J.(1987).Proteins 2,273 -282.
70. Imoto,T., Yamada,H., Yasukochi,T., Yamada,E., Ito,Y., Ueda, T.,
Nagatani,H., Miki,T. and Horiuchi, T. (1987). Protein Engineering 1,
333 -338.
